On July 15, 2025, Cantor Fitzgerald reiterated its "Overweight" rating for MiMedx Group (MDXG, Financial). The analyst, Ross Osborn, confirmed the firm's commitment to its previous position, suggesting continued confidence in the company's market potential.
The price target for MiMedx Group (MDXG, Financial) remains unchanged at $11.00 USD. This target reflects a maintained outlook by Cantor Fitzgerald, indicating that the valuation of MiMedx Group's stock is anticipated to stay robust at this level.
The reaffirmation of the "Overweight" rating implies that Cantor Fitzgerald believes MiMedx Group (MDXG, Financial) will outperform the average total return of stocks within its industry sector. This position has been consistent, with no change in the rating or price target since the prior review.
Investors following MiMedx Group (MDXG, Financial) should note that Cantor Fitzgerald’s analysis does not suggest a change in the expected performance of the stock, as both the price target and the rating of "Overweight" remain as previously stated.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 5 analysts, the average target price for MiMedx Group Inc (MDXG, Financial) is $12.00 with a high estimate of $13.00 and a low estimate of $11.00. The average target implies an upside of 76.47% from the current price of $6.80. More detailed estimate data can be found on the MiMedx Group Inc (MDXG) Forecast page.
Based on the consensus recommendation from 5 brokerage firms, MiMedx Group Inc's (MDXG, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for MiMedx Group Inc (MDXG, Financial) in one year is $7.45, suggesting a upside of 9.56% from the current price of $6.8. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the MiMedx Group Inc (MDXG) Summary page.
